Ranitidine Hydrochloridis CAS 66357-59-3
Shanghai Ruifu Chemical Co., Ltd. est opifex primas Ranitidinis hydrochloridis (CAS: 66357-59-3) cum qualitate alta.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Ranitidine Hydrochloridis,Please contact: alvin@ruifuchem.com
Nomen chemicum | Ranitidine Hydrochloride |
Synonyma | Ranitidine HCl;Zantac;Zantadin;Zintac;Triticum aestivum;N-[2-[5-[(Dimethylamino)methyl]furfurylthio]ethyl]-N'-Methyl-2-Nitro-1,1-Ethenediamine Hydrochloride;N,N Dimethyl-5-[2-(1-Methylamine-2-Nitrovinyl)-Ethylthiomethyl]furfurylamine Hydrochloride |
Stock Status | In Stock, Commercial Productio |
CAS Number | 66357-59-3 |
Related CAS | 71130-06-8 |
Formulae hypotheticae | C13H22N4O3S·HCl |
M. Pondus | 350.86 g/mol |
Liquescens punctum | 134℃(dec.) |
Sensitiva | Hygroscopic, Aeris Sensitiva, Caloris Sensitiva |
Repono Nativ. | Frigus & siccum (2~8℃) |
COA & MSDS | Praesto |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Items | Specifications | Proventus |
Aspectus | Alba ad Off-White Crystalline pulveris | Obsequitur |
Lepidium sativum | Infrared effusio | Obsequitur |
Lepidium sativum B * | Absorptio Ultraviolet | Obsequitur |
Lepidium sativum C* | Probat Chloride | Obsequitur |
pH* | 4.5~6.0 | 5.42 |
Damnum in Siccatio | <0.75% | 0.32% |
Residere in Ignition | <0.10% | 0.05% |
Ranitidine Bis Compositum | <0.30% | 0.04% |
Alia alia immunditia | <0.10% | 0.04% |
Totalis immunditias | <0.50% | 0.16% |
Asssay / Analysis Methodo | 97.5~ 102.0% (Ratio in Basis arida) | 99.70% |
conclusio | Productum probatum est et cum USP35 specificationibus obtemperat | |
Fasciae vita | XXIV menses si proprie Repono |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.Aufer a robusto, dirige lumen et umorem, fuge ignem et calorem.Agentibus oxidizing repugnat.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Ranitidine Hydrochloride
C13H22N4O3S·HCl 350.87
1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-N¢-methyl-2-nitro-, monohydrochloride.
N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N¢-methyl-2-nitro-1,1-ethenediamine, hydrochloride [66357-59-3 ].
Ranitidine hydrochloridum non minus quam 97.5 centesimas continet et non plus quam 102.0 centesimas C13H22N4O3S·HCl in fundamento exsiccato continet.
Packaging ac repono-Conserve in strictis, levibus vasis repugnantibus.
USP Reference signa <11>-
USP Ranitidine Hydrochloride RS
USP Ranitidine Resolutionum Mixturae RS
Mixtura est ex ranitidine hydrochloridis et quatuor immunditiis affinis: ranitidine-N-oxydi, ranitidine complexu nitroacetamide, ranitidine diamine hemifumarate, et ranitidine amino alcoholis hemifumarate.
Ranitidine-N-oxide: N,N-dimethyl[5-[[[2-[[1-(methylamino)-2-nitroethenyl]amino]ethyl]sulphanyl]methyl]furan-2-yl] methanamine N-oxide.
Ranitidine complexu nitroacetamide: N-[2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulphanyl]ethyl]-2-nitroacetamide.
Ranitidine diamine hemifumarate (com- latum A): 5-[[(2-aminoethyl)thio]methyl]-N, N-dimethyl-2-furanmethanamine, sal hemifumaratum.
Ranitidine amino alcohol hemifumarate: [5-[(dimethylamino)methyl]furan-2-yl] methanolum.
Identification-
A: Absorptio infrared <197M>.
B: Absorptio Ultraviolet <197U>-
Solutio: 10 µg per mL.
Medium: aqua.
Absorptivitates ad 229 um et 315 um, fundamento siccato computatae, non plus quam 3.0% differunt.
C: Solutio ejus exigentiis probationum pro Chloride occurrit <191>.
inter 4.5 et 6.0, in solutione (1 in 100).
Amissio siccitate <731>- sicca in vacuo ad 60 pro 3 horis: non plus quam 0.75% sui ponderis amittit.
Residere ignitionem <281>: non plus quam 0,1%.
Chromatographic puritatis
Diluens, mobile Phase, resolutio solutionis et systematis chromatographici-Perge uti in Perge.
Standard solution-Prepara ut ordinatur ad praeparationem Latin in Assay.
Expertus solutionem-Para ut ordinatur ad praeparationem ad Assay in Assay.
De modo procedendi-Separatim inferunt paria volumina (circa 10 µL) solutionis vexilliferae et solutionis testium in chromatographum, chromatogrammata notare, et cacuminum ranitidinem recognoscere et cacumina ob immunditias et degradationes productorum in tabula infra recensita.
Nomen relativum retentionis Tempus
Ranitidine simplicis nitroacetamide1 0.14
Ranitidine oxime2 0.21
Ranitidine amino alcohol3 0.45
Ranitidine diamine4 0.57
Ranitidine S-oxide5 0.64
Ranitidine N-oxide6 0.72
Ranitidine complexi nitroacetamide7 0.84
Ranitidine formaldehyde adduct8 1.36
Ranitidine bis-compound9 1.75
1 N-Methyl-2-nitroacetamide.
2 3-(Methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one oxime.
3 {5-[(Dimethylamino)methyl]furan-2-yl} methanolum.
4 5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine (ranitidine affinis A mixti).
5 N-{2-[({5-[(Dimethylamino)methyl]-2-furanyl}methyl)sulfinyl]ethyl}-N¢-methyl-2-nitro-1,1-ethenediamine (ranitidine affinis C).
6 N, N-Dimethyl(5-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)
sulphanyl]methyl}furan-2-yl)methanamine N-oxide.
7 N-{2-[({5-[(Dimethylamino)methyl]furan-2-yl}methyl)sulphanyl]ethyl}-2-nitroacetamide.
8 2,2¢. diamine).
9 N,N¢-bis{2-[({5-[(Dimethylamino)methyl]-2-furanyl}methyl)thio]ethyl}-2-nitro-1,1-ethenediamine (ranitidine affinis mixti B).
Responsiones ad cacumina maiora metire, et recipis cuiuslibet immunditiae in portione Ranitidini hydrochloridis sumta computare per formulam:
100CV/W(ri/rS)
in qua C est concentratio in mg per mL, hydrochloridi ranitidini in solutione Vexillima;V est volumen in mL, solutionis Test.W est pondus, in mg, de Hydrochloride Ranitidine sumptum ad solutionem Testam praeparandam;ri* est apicem responsio pro qualibet immunditia ex testi solutione impetrata;et rS ranitidine apicem responsionis ex solutione Latin impetrata: non plus quam 0.3% ex ranitidine bis-com- posita, non plus quam 0.1% alterius cujusvis impuritatis reperitur, nec plus quam 0.5% totius immunditiae reperitur. .Renuntiatio campestri ad immunditias 0.05% est.
Assay-
Phosphate quiddam-Locum circa 1900 mL aquae in lagena voluminis 2.0-L, accurate adde 6.8 mL acidi phosphorici, et misce.Accurate adde solutionem hydroxidi sodii 8.6 mL%%, et cum aqua ad volumen dilutum.Si opus est, compone cum solutione hydroxidi sodium 50 vel acidum phosphoricum ad pH 7.1, et sparguntur.
Solutio A-Para mixturam quiddam phosphatis et acetonitrile (98:2).
Solutio B-Para mixturam quiddam phosphatis et acetonitrile (78:22).
Mobile phase-Usus mixtura variabilis Solutio A et Solutio B ut ad systema chromatographicum ordinatur.Fac si opus sit adaptationes (cf. Systema Suitability sub Chromatographia 621).
Diluent-usus Solutio A.
Praeparatio-dissolve accurate ponderata quantitatem USP Ranitidinis hydrochloridis RS in Diluent ad solutionem obtinendam habens notam intentionem circa 0.125 mg ranitidini hydrochloridis per mL.
Resolutio solutionis Translatio circa 1.3 mg USP Ranitidinis Resolutionis Mixturae RS ad 10-mL lagena voluminis triplicata, et dissolve et diluta ad volumen diluendum.[note-USP Ranitidine Resolutionum Mixtura RS, ranitidinem hydrochloridem continet et immunitates quatuor cognatas: ranitidinem amino alcohol hemifumarate, ranitidine diamine hemifumarate, ranitidinem N-oxydatum, et ranitidinem nitroacetamide complexum.]
Praeparatio praeparatio-Translatio circiter 25 mg Hydrochloridis Ranitidini, accurate perpensis, ad 200-mL lagena voluminis triplicata est.Dissolve, ac dilue, dilue ad volumen, ac permisce.
Systema chromatographicum (vide chromatographia <621>) - Chromatographum liquidum cum detectore 230-um instructum et 4.6-mm × 10-cm columna continens 3.5-µm stipare L1 stabilis ab pH 1 ad 12. rate fluxus est. circiter 1.5 ml per minute.Columella temperatura conservatur 35. Chromatographum hoc modo programmata est.
Solutio tempus (minuta) Solutio A (%) Solutio B (%) Elution
0-10 100®0 0®100 clivus linearis
10-15 0 100 isocratic
15-16 0®100 100®0 gradiente lineari
16-20 100 0 re-equilibrationChromatographorum solutionis resolutio, et iugis utens mensae immunditiae et degradationis productorum (inventus supra): resolutio, R, inter apices pro ranitidine N-oxide et ranitidine complexu nitroacetamide non minus est. 1.5.Chromatographum Praeparatio Standard, et refero apicem responsionum ad procedendum ordinatum: vexillum relativum declinationis ad injectiones replicatae non plus quam 1.0%.
De modo procedendi-Separatim injiciunt paria volumina (circa 10 µL) praeparationis vexilliferae et praeparationis in chromatographorum, chromatogrammata notare et areas ad cacumina maiora metire.Recipis C13H22N4O3S·HCl in portione Ranitidini hydrochloridi sumpta formula:
100(CS/CU)(rU/rS)
in quibus CS et CU sunt concentrationes, in mg per mL, ranitidine hydrochloridi in praeparatione Vexillima et Praeparatione Prima, respective;and rU and rS are the apicem responses obtained from the Assy preparation and the Latin preparation, respectively.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Annorum Usus?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Safety Description S22 - Pulverem ne respirare.
S24/25 - contactus cum cute et oculis fuge.
WGK Germania 2
RTECS KM6557000
Ranitidinum hydrochloridum (CAS: 66357-59-3) est genus histaminis H2-receptoris antagonistae, quod secretionem acidum gastricum vetat.Antiulcerativum.Cum eius enumeratio anno 1981, Ranitidine Hydrochloride late in centum fere regionibus in mundo, in Sinis, incluso, usus est.Amet in curatione ulceris duodeni, refluxus esophagitis et syndrome Zollinger-Ellison.Utitur etiam ad impediendum sanguinem gastrointestinorum causatur ex ulcere accentus et recurrente haemorrhagia ulceris peptici.Superioribus decenniis, per ranitidinem et alia medicamenta compositum, invenit habere summam efficaciam et notabilem notam in curatione ulceris duodeni pylori-positivi, urticaria et haemorrhagiae post-cerebralis ulceris efficacia meliore efficacia quam alia similia medicamenta. .Ob celeri effectu, bona potentia et parvo pretio, ranitidine hydrochloride magnas partes agit in foro medicamento anti-ulceris hodie.Ergo severa qualitas temperantiae magnas partes agit in regendis aegris cum rationabili, tutae medicamento.Ranitidine etiam e regione et aliis antihistaminis ad curationem cutis condicionis adhibetur.Ranitidine HCl venales sunt sub nomine notae Zinetac vel Zantac.Pro histamine H2 receptor obstructor, qui secretionem acidi gastrici fundamentalis et acidi gastrici post excitationem inhibere potest, necnon secretio pepsin. Inhibitio acidum 5~8 pluries est quam Cimetidine.
Ad curationem ulceris duodeni, ulceris gastrici, refluxus esophagitis, Zollinger-Ellison syndrome et aliae perturbationes acidi secretionis altae.
Communes motus sunt: nausea, temeraria, constipatio, lassitudo, capitis, vertigo et alia huiusmodi.
Leves reactiones adversae in functione renali, functione gonadal et systematis nervosi centralis.
Parvus numerus aegrorum mitem iecoris damnum accipit post medicamentum cum symptomatis evanescentibus capto, munus iecoris ad normalem rediit.
Ranitidine hydrochloride, antagonista H2-receptor, contactum dermatitis in pharmaceutica industria et in sanitate operariorum causare potest, vel systemica medicamentorum reactiones in aegris inducere potest.